Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study.

Hartung, Hans-Peter; Graf, Jonas; Kremer, David

Hartung, Hans-Peter; Graf, Jonas; Kremer, David.

Afiliação

Hartung HP; Department of Neurology, UKD, Center for Neurology and Neuropsychiatry, LVR Klinikum Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. hans-peter.hartung@uni-duesseldorf.de.
Graf J; Department of Neurology, UKD, Center for Neurology and Neuropsychiatry, LVR Klinikum Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Kremer D; Department of Neurology, UKD, Center for Neurology and Neuropsychiatry, LVR Klinikum Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.

J Neurol ; 267(2): 308-316, 2020 Feb.

Article em En | MEDLINE | ID: mdl-30610426

Assuntos

Esclerose Múltipla/terapia; Diagnóstico Precoce; Acetato de Glatiramer/uso terapêutico; Humanos; Interferon beta-1b/uso terapêutico; Resultado do Tratamento

Palavras-chave

BENEFIT 11 study; Clinically isolated syndrome; Early treatment; Long-term follow-up; Multiple sclerosis; Real world data

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google